Catamount Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

Catamount Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$17K	Hold	1,150	–	–	0.01%	119
2018 Q4	$18K	Hold	1,150	–	–	0.01%	106
2018 Q3	$17K	Hold	1,150	–	–	0.01%	125
2018 Q2	$21K	Hold	1,150	–	–	0.01%	113
2018 Q1	$29K	Hold	1,150	–	–	0.02%	99
2017 Q4	$21K	Hold	1,150	–	–	0.01%	114
2017 Q3	$12K	Hold	1,150	–	–	0.01%	127
2017 Q2	$14K	Hold	1,150	–	–	0.01%	126
2017 Q1	$12K	Hold	1,150	–	–	0.01%	128
2016 Q4	$18K	Hold	1,150	–	–	0.01%	106
2016 Q3	$20K	Hold	1,150	–	–	0.02%	96
2016 Q2	$14K	Hold	1,150	–	–	0.02%	84
2016 Q1	$21K	Buy	1,150 +600	+109%	+$10.9K	0.02%	74
2015 Q4	$15K	Buy	+550	New	+$11.6K	0.01%	84

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Catamount Wealth Management's COLL Position: Q1 2019 in Review

Catamount Wealth Management held its Collegium Pharmaceutical (COLL) position steady in Q1 2019 at 1,150 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #119.

Catamount Wealth Management first reported a position in COLL in Q4 2015 and has held it in 14 quarters since. The position peaked at $29K in Q1 2018. 145 funds tracked by Wall St. Rank hold COLL as of Q1 2019.

Catamount Wealth Management held 1,150 shares of Collegium Pharmaceutical worth $17K as of Q1 2019.
Catamount Wealth Management left its Collegium Pharmaceutical share count unchanged in Q1 2019.
Collegium Pharmaceutical made up 0.01% of Catamount Wealth Management's portfolio in Q1 2019, its #119 holding.
Catamount Wealth Management first reported a position in Collegium Pharmaceutical in Q4 2015 and has held it in 14 quarters since.
Catamount Wealth Management's Collegium Pharmaceutical position peaked at $29K in Q1 2018.
145 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2019.

Based on Catamount Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.